H.R. 846 (119th)Bill Overview

SAD Act

Health|AbortionCivil actions and liability
Cosponsors
Support
Democratic
Introduced
Jan 31, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the House Committee on Energy and Commerce.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

This bill makes it unlawful to place deceptive advertising about reproductive health services, specifically prohibiting false claims about offering abortion or contraception services or employing licensed medical personnel. It directs the Federal Trade Commission to issue rules, enforce the prohibition (including against nonprofits), seek civil remedies and penalties, and report to Congress biennially.

Why people may split

Left emphasizes protecting patients from deception; right emphasizes free speech and religious liberty

Watch point

Relative to its intended legislative type, this bill is a substantive statutory intervention that clearly defines a policy objective and connects enforcement to the FTC framework.

This bill makes it unlawful to place deceptive advertising about reproductive health services, specifically prohibiting false claims about offering abortion or contraception services or employing licensed medical personnel.

It directs the Federal Trade Commission to issue rules, enforce the prohibition (including against nonprofits), seek civil remedies and penalties, and report to Congress biennially.

Penalties may reach the greater of $100,000 (inflation-adjusted) or 50% of the ultimate parent entity’s prior-year revenue.

Passage25/100

Technocratic consumer-protection framing helps, but high ideological salience, constitutional risks, and expanded federal reach reduce overall prospects.

CredibilityPartially aligned

Relative to its intended legislative type, this bill is a substantive statutory intervention that clearly defines a policy objective and connects enforcement to the FTC framework. It provides concrete remedies and penalties and establishes reporting requirements, while integrating with existing FTC authorities.

Contention72/100

Left emphasizes protecting patients from deception; right emphasizes free speech and religious liberty

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
ConsumersLikely burdened

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Potential benefitMay reduce deceptive advertising that misleads patients seeking abortion or contraception information.
  • Potential benefitCould improve timely access to evidence-based reproductive care by preventing diversion to misleading providers.
  • ConsumersExpands FTC enforcement tools, enabling injunctions, civil penalties, and consumer restitution.
Likely burdened
  • Potential burdenCreates compliance costs and administrative burdens for small nonprofits and faith-based organizations.
  • Potential burdenRaises potential First Amendment and free-speech challenges related to advertising regulation and persuasion.
  • Potential burdenCivil penalties up to 50% of parent-entity revenue could financially threaten organizations, including nonprofits.
03 · Why people split

Why the argument around this bill splits.

Left emphasizes protecting patients from deception; right emphasizes free speech and religious liberty
Progressive95%

Likely strongly supportive: views the bill as protecting people seeking reproductive care from deceptive ads and delaying tactics.

Sees FTC enforcement and strong penalties as appropriate responses to protect vulnerable communities, especially those disproportionately harmed after Dobbs.

May note some uncertainty about implementation details.

Leans supportive
Centrist65%

Generally favorable but cautious: supports consumer-protection aims while worrying about legal clarity and administrative costs.

Sees value in curbing deceptive practices but wants precise definitions, due process safeguards, and limits on overly punitive remedies.

Finds FTC enforcement role reasonable if rules are tightly crafted.

Split reaction
Conservative15%

Likely opposed: views the bill as federal overreach that targets faith-based and pro-life organizations.

Sees expansive FTC authority and steep penalties as threats to speech, religious liberty, and nonprofit activity.

Expects litigation and political pushback over scope and constitutionality.

Likely resistant
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood25/100

Technocratic consumer-protection framing helps, but high ideological salience, constitutional risks, and expanded federal reach reduce overall prospects.

Scope and complexity
52%
Scopemoderate
24%
Complexitylow
Why this could stall
  • Likelihood and success of First Amendment legal challenges
  • How courts would construe 'deceptive' in reproductive context
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Left emphasizes protecting patients from deception; right emphasizes free speech and religious liberty

Technocratic consumer-protection framing helps, but high ideological salience, constitutional risks, and expanded federal reach reduce over…

Unlocked analysis

Relative to its intended legislative type, this bill is a substantive statutory intervention that clearly defines a policy objective and connects enforcement to the FTC framework. It provides concrete remedies and penal…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis